Positron emission tomography (PET) with the use of radiopharmaceutical 18-Fluorodeoxyglucose has high specificity and sensitivity, which means this method is the main method in assessment of disease spreading in oncological patients at the moment. In case of suspicion for brain metastatic affection, positron tomography of the whole body allows to reveal the primary nidus and to estimate disease spreading in organism in general. But, despite its advantages, this method has some essential restrictions that do not allow its using as a screening research. First of all, this is highly technical character of the method, production of radiopharmaceutical, its transportation and utilization demand additional staff except for medical personnel, another important aspect is relatively high cost of research. Long time of scanning, restrictions related with accompanying diseases (diabetes) also narrow down potentialities of this method.

If you need Bioplasm nls software,please feel free contact me and i am happy to help you.